2.8. A Multivariate Analysis Confirms PTK2 Overexpression as an Independent Prognostic Factor for OS and DFS in Cytogenetic IR-AML Patients with Non-Favorable FLT3/NPM1 Combinations and PTK2B or LYN Underexpression. The gene discussed is PTK2; the disease is acute myeloid leukemia.